Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The trade-off is less hands-on medical oversight, which some patients may miss if they want ongoing provider engagement or detailed lab monitoring
Abstract Aims/hypothesis Our aim was to assess treatment discontinuation, reinitiation and switching between drugs within the same drug class for glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors in individuals with type 2 diabetes
Participants in both groups were instructed to walk for 30 minutes three times per week
The drugs need to be managed in a unique way, using a new strategy that experts have not quite agreed on yet
US$ 28.63
US$ 23.27
US$ 24.93
